top of page

By:

Abhijit Mulye

21 August 2024 at 4:59:11 pm

MLC polls expose cracks in Mahayuti, MVA

AI Generated Image Mumbai: The upcoming Maharashtra Legislative Council (MLC) elections for the graduate and teacher constituencies have laid bare the deep-seated fissures within both the ruling Mahayuti and the opposition Maha Vikas Aghadi (MVA) alliances. In a significant development that could have far-reaching political implications, multiple rebel candidates, including prominent figures with strong party affiliations, have defied alliance dictates to file their nominations as...

MLC polls expose cracks in Mahayuti, MVA

AI Generated Image Mumbai: The upcoming Maharashtra Legislative Council (MLC) elections for the graduate and teacher constituencies have laid bare the deep-seated fissures within both the ruling Mahayuti and the opposition Maha Vikas Aghadi (MVA) alliances. In a significant development that could have far-reaching political implications, multiple rebel candidates, including prominent figures with strong party affiliations, have defied alliance dictates to file their nominations as independents, setting the stage for high-stakes, multi-cornered contests. Mahayuti Turmoil The Mahayuti alliance, comprising the Bharatiya Janata Party (BJP), the Eknath Shinde-led Shiv Sena, and the Ajit Pawar-led Nationalist Congress Party (NCP), is grappling with rebellion on multiple fronts. In the critical Nagpur Graduates constituency, a traditional BJP stronghold, former BJP MLC and Nagpur Mayor Anil Sole has thrown a spanner in the works by filing his nomination as an independent candidate. This move directly challenges the official BJP candidate, Sudhakar Kohale. While the BJP leadership, including state president Ravindra Chavan, has attempted to downplay the situation, asserting that Sole has been "pacified," the former MLC's actions tell a different story. Sole's decision to contest independently is particularly significant given his long-standing association with the Rashtriya Swayamsevak Sangh (RSS) and his previous stint as a BJP MLC from the very same constituency. The situation is equally complicated in the Amravati Teachers constituency. The Shiv Sena (Shinde faction) has officially fielded Kiran Sarnaik. However, adding to the confusion, Sangita Shinde, sister of BJP MP Anil Bonde, has also entered the fray, potentially splitting the Mahayuti vote. The opposition MVA is also facing its share of internal discord here. While the Congress has nominated Aditi Pohre, daughter of former minister Harshvardhan Deshmukh, the Shiv Sena (UBT) has fielded Dattatray Lahane. The presence of numerous candidates representing various teachers' organizations further complicates the electoral arithmetic in this constituency. Opposition Rebellion The Chhatrapati Sambhaji Nagar Graduates constituency has witnessed another surprise development. While the NCP's sitting MLC, Satish Chavan, was widely considered the frontrunner, the BJP's M.K. Deshmukh has unexpectedly filed his nomination as a rebel candidate, catching the Mahayuti leadership completely off guard. The MVA, too, is facing rebellion in this constituency. Although the seat was officially allocated to the NCP (Sharad Pawar faction), Shiv Sena (UBT)'s Dilip Ghuge has also filed his nomination, causing significant heartburn within the opposition alliance. The Pune constituencies present a microcosm of the larger alliance troubles. In the Pune Graduates constituency, the BJP has fielded Dr. Smita Jadhav, the daughter-in-law of Pratap Singh Jadhav, owner of the 'Pudhari' news group and niece of Congress leader Satej Patil. Adding intrigue to this contest is the fact that she is contesting against Harshada Deshmukh-Jadhav, the official candidate of the NCP (Sharad Pawar faction). However, the real drama is unfolding in the Pune Teachers constituency. The BJP's official candidate, Koustubh Gawde, is facing a formidable challenge from Mangesh Chiwate, a close confidant of Chief Minister Eknath Shinde. Chiwate, a former journalist who handled the CM's medical aid cell while Shinde was the CM, has claimed that his party leadership has provided him with the crucial 'AB' form, signaling official backing. Commenting on the chaotic situation, Chief Minister Devendra Fadnavis acknowledged that seat-sharing talks remained inconclusive in some areas but expressed hope that the alliance partners would eventually reach an agreement. The true picture of the electoral battlefield will only emerge after Friday, October 9th, the last date for the withdrawal of nominations. Until then, both alliances will be working overtime to contain the rebellions and present a united front, but the deep cracks exposed by these developments suggest that the upcoming MLC elections will be fiercely contested and highly unpredictable.

Let Science Be the Referee

While Homoeopathy should face rigorous scientific scrutiny, neither its critics nor its proponents should decide the answer before the evidence is in.

Our previous article, “Homoeopathy, As We Know It,” received both bouquets and brickbats. That was not surprising. Homoeopathy has had a long history of practice and research, yet continues to generate sharply divided opinions. What surprised us was the nature of some of the criticism.


Homoeopathy has more than two centuries of clinical experience and a growing body of research. Modern science now gives us an opportunity to investigate its underlying phenomena more deeply than ever before. Today, science has tools far more powerful than those available even a few decades ago. Why not use them to examine homoeopathy more deeply? What happens in highly diluted preparations? Are the observed effects reproducible? Do they produce measurable changes in biological systems? What could these findings mean for patients? Such questions require rigorous, independently verified evidence.


Yet, some critics responded that homoeopathy was “quackery,” that the matter was already settled and that further research was unnecessary. Some went further, predicting that research sponsored by the Central Council for Research in Homoeopathy (CCRH) would inevitably be biased and poorly designed. This raises a basic question. Can we render a verdict before conducting the experiment?


Scepticism or Prejudgment?

Science cannot progress without scepticism. Every scientific claim must remain open to scrutiny. But scepticism and prejudgment are not the same. A true sceptic asks for evidence. Yet some critics seem to have already decided that homoeopathy cannot work and therefore see no reason to investigate it further. Is that really scientific scepticism? Science should neither begin with belief nor disbelief. It should ask the right questions, conduct sound experiments and accept what the evidence shows.


A study should be judged by how it is conducted and whether its findings can be reproduced, not by the label attached to the system under study. Criticizing research after examining it is science. Predicting its failure before it begins is prejudgment.

There is also a misconception that research in homoeopathy means homoeopathic practitioners working among themselves to prove what they already believe. The reality is quite different. CCRH is already investigating high dilutions through physicochemical, biological and nanotechnology-based studies in collaboration with leading institutions, including IITs, ICMR, NIMHANS, Delhi University, the University of Calcutta, ICAR institutes and other centres of scientific excellence.


These collaborations bring contemporary science directly into homoeopathy research. They use approaches ranging from nanoscience and molecular biology to omics, artificial intelligence, computational analysis and advanced analytical techniques. These are mainstream scientific tools used across biomedical research. What ultimately matters is whether the research is rigorous, reproducible and independently verifiable.


CCRH’s scientific responsibility is to strengthen the evidence base for homoeopathy through such rigorous laboratory research, well-designed clinical studies and collaboration with leading scientific institutions. This builds directly on the multidisciplinary approach described in the attached draft.


Revisiting Assumptions

A common argument is that homoeopathy has already been studied, so why “reinvent the wheel”? But revisiting a question is not reinventing the wheel when instruments become more sensitive, methods improve and new questions become possible. This does not mean simply repeating earlier studies. New research must advance the subject with better tools, stronger controls or questions that earlier studies could not adequately address. We should not revisit a question because we dislike an earlier answer. We should revisit it when we can ask the question more effectively.


Scientific knowledge is not a collection of conclusions permanently carved in stone. It advances because earlier observations are revisited, explanations are challenged and accepted ideas are retested when new methods become available. Re-examination is not a weakness of science but one of its greatest strengths.


One critic made an extraordinary suggestion: people who use homoeopathy should avoid modern medicine altogether. But why should healthcare demand such loyalty? A patient does not have to “belong” to homoeopathy, modern medicine or any other system. The real question is simpler. What does reliable evidence tell us about a treatment for a particular patient and condition?


Ultimately, neither the patient nor the physician should be loyal to a medical system. Both should be loyal to evidence. During COVID-19, early studies suggested that remdesivir could shorten recovery time, while the much larger WHO Solidarity trial later found little to no effect on mortality among hospitalised patients. As more evidence emerged, recommendations evolved. That was not a failure of modern medicine. It was science working as it should. When evidence changes, conclusions must be allowed to change too.


Confirmation bias is a concern in all research, not something unique to homoeopathy. Researchers in every field can be influenced by what they expect or hope to find. Biomedical research must also guard against selective reporting, conflicts of interest and commercial pressures. Science has ways of addressing such risks: proper controls, disclosure of conflicts, peer review and independent replication. We do not reject a pharmaceutical study simply because the company sponsoring it has a commercial interest in a positive result. Why should the principle be different for research in homoeopathy?


Homoeopathy should face rigorous scientific scrutiny without being prejudged. Its critics must be equally willing to accept reproducible evidence, including findings that challenge current understanding. Science demands this openness from both sides. Neither side gets to decide the answer in advance. Let the experiment be the referee.

 

(Dr. Kaushik is Director General, Central Council for Research in Homoeopathy (CCRH), Ministry of Ayush, New Delhi. Dr. Paknikar is a Member of the Scientific Advisory Board, CCRH, New Delhi, and ANRF Prime Minister Professor, COEP Technological University, Pune. Views personal.)

Comments


bottom of page